摘要
心血管疾病是危害人类健康的常见病之一,发病率逐年上升,并趋于年轻化,一直备受全球关注。我国成年人心衰的患病率大约在0.9%,每年死于心血管病的人数达到数百万,心衰死亡率高,财政花费大,在诊断后有85%男性和65%的女性在6年内死亡,出院病人6个月内再住院率55%。心衰已成为心血管疾病中迫切需要解决和攻克的难题,也是我们即将面临的新挑战。而能及时预测心衰的风险、准确判断提供风险信息十分重要,本文就心血管疾病的终末阶段心衰及其相关的重要标志物做一综述。
Cardiovascular disease is one of the common diseases that endanger human health. The incidence rate of cardiovascular disease increases year by year, and tends to be younger, is getting the attention from the whole world. The adult with heart failure in our country has gone to 0.9%. The number of people dying of cardiovascular disease in China every year has reached to millions. Heart failure with high mortality and finance costly, 85% of men and 65% of female will die in six years after diagnosis. 55% of the patients get out of the hospital then will be back in 6 months. Heart failure has become an urgent problem that needs to be solved and overcome. It is very important to predict the risk of heart failure in time and determine accurately. This review will discuss the terminal of cardiovascular disease, heart failure and relative important biomarkers.
出处
《标记免疫分析与临床》
CAS
2015年第10期982-985,共4页
Labeled Immunoassays and Clinical Medicine
